Persky V, Davis F, Barrett R, Ruby E, Sailer C, Levy P
Epidemiology Program, School of Public Health, University of Illinois, Chicago 60680.
Am J Public Health. 1990 Aug;80(8):935-9. doi: 10.2105/ajph.80.8.935.
Recent trends in corpus uterine cancer incidence rates were explored using 1979-86 data from the Surveillance and End Results Program (SEER); recent trends in hospitalizations for corpus uterine cancer were explored using 1979-86 data from National Hospital Discharge Surveys (NHDS); and recent trends in exogenous hormone use were delineated using data from the 1980, 1981, and 1985 National Ambulatory Medical Care Surveys (NAMCS). Uterine cancer incidence rates using SEER data have continued to decline since 1979. An acceleration in the decline since 1983-84 is suggested in all women and in women with intact uteri ages 45-64. Hospitalizations for uterine cancer have also declined since 1979, with a marked acceleration in the decline since 1983-84 for all women and for women ages 40-79 has increased 22 percent and use of unopposed exogenous estrogens in women of similar age has increased 7 percent, while use of exogenous progesterones have shown much more substantial increases of approximately 700 percent. Possible relationships between trends in exogenous hormone use and incidence rates of corpus uterine cancer are discussed.
利用监测、流行病学和最终结果计划(SEER)1979 - 1986年的数据,探究了子宫体癌发病率的近期趋势;利用国家医院出院调查(NHDS)1979 - 1986年的数据,探究了子宫体癌住院治疗的近期趋势;利用1980年、1981年和1985年国家门诊医疗护理调查(NAMCS)的数据,描绘了外源性激素使用的近期趋势。自1979年以来,使用SEER数据得出的子宫癌发病率持续下降。1983 - 1984年以来,所有女性以及45 - 64岁子宫完整的女性中,发病率下降速度加快。自1979年以来,子宫癌住院治疗人数也在下降,1983 - 1984年以来下降速度明显加快,所有女性以及40 - 79岁女性中,类似年龄女性使用无对抗性外源性雌激素增加了22%,使用外源性孕激素则大幅增加了约700%。讨论了外源性激素使用趋势与子宫体癌发病率之间可能的关系。